Finance News – 3Sbio
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Stocks
Tariffs
Investors
Shares
Stock
Crypto Assets
Stock Market
Cryptocurrency
Ethereum
Price
Markets
Xrp
Stablecoin
Investment
Blockchain
Etf
Bse
Ipo
Eth
Sec
Index
Solana
Trade
Earnings
Inflation
Coinbase
Revenue
Interest Rates
Token
Sensex
China
Wall Street
Nasdaq
Federal Reserve
Traders
Treasury
Nse
Gold
Bse Sensex
Economy
Sp 500
Usd
Profit
Nifty
Tesla
Digital Assets
Crypto Reserve
Chainalysis
Dex Volumes
Freight
Yellow Card
Canadian Bourse
Easing
Tradfi Markets
Delaware Bankruptcy Judge
Mobikwik
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • May 20, 2025
Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China
Pfizer has entered into an agreement potentially valued at $6 billion to distribute a cancer medication developed by 3SBio in international markets beyond China.
Read Full Article →